COVID-19 Temporary Provisions
[Pages:20]COVID-19 Temporary Provisions
Date guide
Information reflects provisions effective as of Oct. 18, 2022. State variations and requirements may apply during this time. As needed, please refer to the Appendix for information on temporary provisions and suspensions that were implemented but are no longer in effect.
? 2022 United HealthCare Services, Inc. All Rights Reserved.
Summary of COVID-19 dates by program
? The following document is intended to be a quick reference guide for the beginning and end dates of temporary program, process or procedure changes that UnitedHealthcare has implemented as a result of COVID-19. Full details of these changes can be found at COVID19.
Please note: Where outlined, changes apply to Individual Exchange, Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary.
? Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your statespecific website or your state's UnitedHealthcare Community Plan website, if applicable. For more details, go to covid19.
? Medical management requirements may also apply, according to the member's benefit plan
2
? 2022 United HealthCare Services, Inc. All Rights Reserved.
Table of contents
Current temporary provisions ? Cost share waivers ? Testing ? Cost share waivers ? Treatment ? Telehealth cost share ? COVID-19 ? Telehealth expansion ? Timely filing ? Referrals and prior authorizations Expired temporary provisions ? Expired provisions ? Resources
3
Current cost share waivers ? Testing
(copays, coinsurance and deductibles)
Program or benefit scenario
COVID-19 diagnostic testing (physician ordered)
Medicare Advantage
Medicaid
Individual and Group Market health plans
Additional details
From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network tests.
State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.
From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for in-network and out-of-network tests.
? UnitedHealthcare will cover medically appropriate COVID-19 testing during the national public health emergency period (currently scheduled to end Jan. 10, 2023), at no cost share, when ordered or reviewed by a physician or appropriately licensed health care professional to either 1) diagnose if the virus is present due to symptoms or potential exposure, or 2) help in the treatment of the virus for a person..
? UnitedHealthcare health plans does not cover COVID-19 surveillance testing, which is testing used for public health or social purposes such as employment (return to workplace), education, travel, or entertainment. These tests are only covered when required by applicable law and adjudicated in accordance with member's benefit plan. o Exception for Administrative Services Only (ASO) plans: Effective Jan. 1, 2022, ASO plans may elect to cover surveillance testing claims administered by a health care provider under the medical benefit plan. Members are responsible for checking with their employer to see if they have elected to cover surveillance testing in 2022.
Over-the-counter (OTC) COVID-19 tests (physician ordered)
From Feb. 4, 2020, through the national State variations and
From Feb. 4, 2020, through the national ?
public health emergency period, currently requirements may apply public health emergency period, currently
scheduled to end Jan. 10, 2023,
during this time. Please scheduled to end Jan. 10, 2023,
UnitedHealthcare is waiving cost share
refer to your state's
UnitedHealthcare is waiving cost share
(copay, coinsurance and deductible) for in- COVID-19-specific
(copay, coinsurance and deductible) for
network and out-of-network tests when
website for more
in-network and out-of-network tests when ?
medically appropriate as ordered or
information.
medically appropriate as ordered or
reviewed by a physician or appropriately
reviewed by a physician or appropriately
licensed health care professional.
licensed health care professional.
Members will be responsible for the cost of OTC tests and may use their health savings account (HSA), flexible spending account (FSA) or health reimbursement account (HRA)
If you provide a prescription for an over-the-counter COVID19 test as part of clinical care, the member may submit a claim for reimbursement with both the prescription and detailed receipt to UnitedHealthcare
4
Current cost share waivers ? Testing (cont.)
(copays, coinsurance and deductibles)
Program or benefit scenario
Over-the-counter (OTC) COVID-19 tests without a prescription
Medicare Advantage
Medicaid
Individual and Group Market health plans
Additional details
Beginning April 4, 2022, all Medicare beneficiaries In accordance with the
Beginning Jan. 15, 2022, UnitedHealthcare ? Members can be reimbursed for up to 8 FDA-
with Part B coverage are eligible to get 8 free
American Rescue Plan, State will cover the cost of FDA-authorized or
authorized or approved OTC at-home diagnostic
FDA-authorized or approved over-the-counter
Medicaid and CHIP programs approved over-the-counter (OTC) at-home tests per covered member every calendar month
(OTC) at-home COVID-19 diagnostic tests every are required to cover FDA- COVID-19 diagnostic tests purchased on
at no cost to the member (no cost-sharing,
calendar month. This includes members enrolled in authorized at-home COVID- or after Jan. 15, 2022. This aligns with the
copay, coinsurance or deductible).
UnitedHealthcare's Medicare Advantage, Medicare 19 tests. People with
guidance released on Jan. 10, 2022, by
o The FDA website lists tests that fit these
Supplement and Medicare Prescription Drug plans. Medicaid or CHIP coverage the Departments of Labor, Treasury and
criteria
should contact their state
Health and Human Services (Tri-Agencies) o The limit of 8 tests per member every
The initiative runs from April 4, 2022 through the
Medicaid or CHIP agency for to support the Biden Administration's
calendar month does not apply to Standard
end of the national public health emergency period, information regarding the
directive on OTC at-home testing.
PCR tests administered by a doctor and
currently scheduled to end Jan. 10, 2023.
specifics of coverage for at-
processed by a lab.
home COVID-19 tests, as
UnitedHealthcare will not require a prior
o Members do not need a prescription to
For members enrolled in a Medicare Advantage
coverage rules may vary by authorization, to be reimbursed for the
request the OTC tests
plan, the tests covered under this initiative will be state.
OTC at-home tests.
? To qualify for coverage, members must
covered outside of the existing plan's coverage, and
purchase the OTC tests on or after the following
in addition to any over-the-counter tests that may be
dates, based on the type of health plan the
covered under the plan as a supplemental benefit.
member has. Tests purchased prior to that date
are not eligible for reimbursement:
Free COVID-19 tests for Medicare beneficiaries are
o Medicare: April 4, 2022
available at participating pharmacies, including
o Individual and Group Market: Jan. 15, 2022
CVS, Costco, Walgreens and Walmart.
o Medicaid: Varies by state
? Participating pharmacies can provide the tests
and bill Medicare on the member's behalf.
? Members are encouraged to bring their red,
white and blue Medicare card ? which is different
than the plan ID card ? to get the free tests.
However, the pharmacy may be able to bill
Medicare without the card.
5
Current cost share waivers ? Testing (cont.)
(copays, coinsurance and deductibles)
Program or benefit scenario
COVID-19 antibody testing
Medicare Advantage
From April 10, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network tests.
COVID-19 testingrelated services
From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network testing-related services.
Medicaid
Individual and Group Market health plans
Additional details
State variations and requirements may apply during this time. Please refer to your state's COVID-19specific website for more information.
From April 10, 2020, through the
?
national public health emergency
period, currently scheduled to end Jan.
10, 2023, UnitedHealthcare is waiving
cost share for in-network and out-of-
network tests.
COVID-19 antibody testing must be an FDA-authorized test ordered by a physician or appropriately licensed health care professional, consistent with Centers for Medicare & Medicaid Services (CMS) requirements
State variations and requirements may apply during this time. Please refer to your state's COVID-19specific website for more information.
From Feb. 4, 2020, through the national ? public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share for in-network and out-of-network testing-related services.
Services can be in person or via telehealth
6
Current cost share waivers ? Treatment
(copays, coinsurance and deductibles)
Program or benefit scenario
Medicare Advantage
COVID-19 treatment
As of April 1, 2021, no cost share waivers are in effect. Coverage and cost share (copay, coinsurance and deductible), including out-of-network costs, are adjudicated in accordance with the member's health plan. This includes telehealth, inpatient and outpatient COVID-19 treatment for both in-network and out-of-network services.
COVID-19 antiviral treatment
For Medicare health plans, administration claims for FDA-authorized or approved COVID-19 antiviral treatments for Medicare beneficiaries will be reimbursed with no cost share (copayment, coinsurance or deductible) through the national public health emergency, currently scheduled to end Jan. 10, 2023.
Medicaid
State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.
State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.
Reimbursement and cost share waivers are limited to antiviral treatments that are FDA-authorized or approved at the time of treatment.
Individual and Group Market fully insured health plans
No cost share waivers are currently in effect. Coverage and cost share (copay, coinsurance and deductible), including out-of-network costs, are adjudicated in accordance with the member's health plan.
Additional details
No cost share waivers are currently in effect. For medical health plans, coverage and cost share for both in-network and out-of-network treatment are adjudicated in accordance with the member's health plan.
As of April 4, 2022, there are 3 antiviral treatment options available:
Infusion ? Veklury (Remdesiver)
Oral ? Paxlovid (nirmatrelvir + ritonavir, co-
packaged) ? Lagevrio (molnupiravir)
Please review the COVID-19 Billing Guide and our website for additional antiviral treatment information.
State variations and requirements may apply during this time. Changes apply to Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary. Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your state-specific website or your state's UnitedHealthcare Community Plan website, if applicable. See covid19 for more 7 details. Dates are subject to change, based on the national public health emergency provisions.
Current cost share waivers ? Treatment
(copays, coinsurance and deductibles)
Program or benefit scenario
Monoclonal antibody treatment
Medicare Advantage
Medicaid
Individual and Group Market fully insured health plans
Additional details
For Medicare health plans, administration claims for FDAauthorized or approved COVID19 monoclonal antibody treatments for Medicare beneficiaries will be reimbursed with no cost share (copayment, coinsurance or deductible) through the national public health emergency.
Reimbursement and cost share waivers are limited to monoclonal antibody treatments that are FDA-authorized or approved at the time of treatment.
State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.
For Individual Exchange, Individual and Group Market health plans, the investigational monoclonal antibody treatment will be considered a covered benefit during the national public health emergency period, currently scheduled to end Jan. 10, 2023. Patients should meet the emergency use authorization (EUA) criteria for FDA-authorized or approved monoclonal antibody treatment in an outpatient setting.
As of April 1, 2021, no cost share waivers are in effect for the administration (intravenous infusion) of monoclonal antibodies. Coverage and cost share for both in-network and out-of-network treatment are adjudicated in accordance with the member's health plan.
As of April 5, 2022, there are 2 monoclonal antibody treatment options available: ? Bebtelovimab ? Evusheld (pre-exposure prophylaxis use only)
Please review the COVID-19 Billing Guide and our website for monoclonal antibody treatment information.
State variations and requirements may apply during this time. Changes apply to Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary. Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your state-specific website or your state's UnitedHealthcare Community Plan website, if applicable. See covid19 for more 8 details. Dates are subject to change, based on the national public health emergency provisions.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- the invisible contours of online dating communities a
- federal bureau of investigation official notification
- covid 19 temporary provisions
- the geography of online dating fraud
- ativan lorazepam injection
- dating matters youth programs at a glance
- historic artifact identification guide
- online dating a critical analysis from the
- a comparison and review of window glass analysis
- guide to dating curt teich postcards
Related searches
- wells fargo covid 19 relief
- covid 19 late car payments
- covid 19 birthday party ideas
- cms reimbursement for covid 19 testing
- covid 19 medicare billing guidelines
- billing for covid 19 screening
- chop covid 19 pathway
- bc government covid 19 update
- covid 19 update in bc
- oxford covid 19 vaccine
- oxford university covid 19 vaccine
- oxford covid 19 vaccine trial